Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Working Capital Changes (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Other Working Capital Changes for 6 consecutive years, with -$825000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 66.64% year-over-year to -$825000.0, compared with a TTM value of -$3.2 million through Dec 2025, down 29.68%, and an annual FY2025 reading of -$3.2 million, down 29.68% over the prior year.
  • Other Working Capital Changes was -$825000.0 for Q4 2025 at Treace Medical Concepts, up from -$2.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.5 million in Q2 2021 and bottomed at -$2.9 million in Q3 2021.
  • Average Other Working Capital Changes over 5 years is -$16105.3, with a median of -$133000.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes soared 8293.55% in 2021, then tumbled 3326.32% in 2023.
  • Year by year, Other Working Capital Changes stood at $2.4 million in 2021, then dropped by 16.51% to $2.0 million in 2022, then crashed by 156.84% to -$1.1 million in 2023, then crashed by 115.61% to -$2.5 million in 2024, then soared by 66.64% to -$825000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TMCI at -$825000.0 in Q4 2025, -$2.3 million in Q3 2025, and -$57000.0 in Q1 2025.